CD4 and psoriasis: To investigate whether iNKT cells from psoriasis patients exhibited phenotypic abnormalities, we first analyzed the proportion of the CD4+iNKT subset in the PBMCs, but no significant differences were detected between psoriasis patients and healthy controls (Figures 3C,D).